Back
Day Range
$83.01
$90.00
52-Week Range
$60.00
$90.00
Volume
149
50D / 200D Avg
$87.90
/
$77.48
Prev Close
$90.00
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 12.6 | 10.4 |
| P/B | 1.9 | 1.2 |
| ROE % | 15.8 | 12.3 |
| Net Margin % | 14.1 | 5.2 |
| Rev Growth 5Y % | 6.4 | 5.5 |
| D/E | 0.3 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$7.00
$6.95 – $7.11
|
1.9 B | 1 |
| FY2028 |
$5.66
$5.61 – $5.74
|
1.8 B | 1 |
| FY2027 |
$5.43
$5.39 – $5.51
|
1.7 B | 1 |
Key Takeaways
Revenue grew 6.36% annually over 5 years — modest growth
Earnings grew 80.65% over the past year
ROE of 15.75% — decent returns on equity
Debt/Equity of 0.30 — conservative balance sheet
Generating 118.42M in free cash flow
P/E of 12.57 — trading at a low valuation
Growth
Revenue Growth (5Y)
6.36%
Revenue (1Y)-0.09%
Earnings (1Y)80.65%
FCF Growth (3Y)83.58%
Quality
Return on Equity
15.75%
ROIC8.91%
Net Margin14.10%
Op. Margin14.77%
Safety
Debt / Equity
0.30
Current Ratio2.97
Interest Coverage21.99
Valuation
P/E Ratio
12.57
P/B Ratio1.85
EV/EBITDA12.44
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.09% | Revenue Growth (3Y) | 5.71% |
| Earnings Growth (1Y) | 80.65% | Earnings Growth (3Y) | 36.42% |
| Revenue Growth (5Y) | 6.36% | Earnings Growth (5Y) | 20.90% |
| Profitability | |||
| Revenue (TTM) | 1.68B | Net Income (TTM) | 236.35M |
| ROE | 15.75% | ROA | 8.83% |
| Gross Margin | 63.07% | Operating Margin | 14.77% |
| Net Margin | 14.10% | Free Cash Flow (TTM) | 118.42M |
| ROIC | 8.91% | FCF Growth (3Y) | 83.58% |
| Safety | |||
| Debt / Equity | 0.30 | Current Ratio | 2.97 |
| Interest Coverage | 21.99 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 12.57 | P/B Ratio | 1.85 |
| P/S Ratio | 1.77 | PEG Ratio | -7.38 |
| EV/EBITDA | 12.44 | Dividend Yield | 0.01% |
| Market Cap | 2.97B | Enterprise Value | 3.08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 1.68B | 1.50B | 1.54B | 1.31B |
| Net Income | 236.35M | 130.83M | 126.99M | 107.76M | 110.61M |
| EPS (Diluted) | 4.24 | 3.96 | 3.85 | 3.27 | 3.35 |
| Gross Profit | 1.06B | 1.06B | 910.40M | 845.21M | 739.54M |
| Operating Income | 247.63M | 301.95M | 195.11M | 155.06M | 137.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.68B | 2.96B | 2.75B | 2.65B | 2.38B |
| Total Liabilities | 1.07B | 1.56B | 1.46B | 1.41B | 1.32B |
| Shareholders' Equity | 1.60B | 1.40B | 1.29B | 1.25B | 1.05B |
| Total Debt | 483.53M | 658.79M | 785.14M | 770.00M | 742.20M |
| Cash & Equivalents | 373.99M | 222.36M | 173.00M | 203.66M | 222.75M |
| Current Assets | 1.55B | 1.74B | 1.42B | 1.33B | 1.11B |
| Current Liabilities | 521.39M | 946.19M | 696.49M | 591.72M | 484.02M |
Strategy Scores
This stock passed the criteria for 0 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recent Activity
Exited
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026